Understanding Fisker’s Unusual Options Activity
Shares of Fisker (NYSE:FSR) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved down to $17.93.
85 Biggest Movers From Yesterday
Gainers
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.
PreMarket Prep Stock Of The Day: Fisker
Benzinga's PreMarket Prep airs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders and investors tune in to get the major news of the day, the catalysts behind those moves and the corresponding price action for the upcoming session.
54 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.
Why Fisker’s Stock Is Surging Higher Today
Fisker Inc (NYSE: FSR) is trading significantly higher Tuesday after Morgan Stanley resumed coverage on the stock with a Buy rating and announced a $40 price target.
Morgan Stanley analyst Adam Jonas also set a new $90 bull case on the stock.
Analyzing Fisker’s Unusual Options Activity
Fisker (NYSE:FSR) shares experienced unusual options activity on Tuesday. The stock price moved up to $18.77 following the option alert.
Morgan Stanley Initiates Coverage On Fisker with Overweight Rating, Announces Price Target of $40
Morgan Stanley analyst Adam Jonas initiates coverage on Fisker (NYSE:FSR) with a Overweight rating and announces Price Target of $40.